Fortress Biotech (FBIO) Unit to Present MB-101 Data as GBM Treatment
Tweet Send to a Friend
Mustang Bio, Inc. (“Mustang”), a Fortress Biotech (Nasdaq: FBIO) Company, announced that Phase 1 clinical data and pre-clinical data on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
